AIM ImmunoTech Inc - Company Profile
Powered by 
All the sales intelligence you need on AIM ImmunoTech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how AIM ImmunoTech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with AIM ImmunoTech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on AIM ImmunoTech Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 19 Apr 2023 | AIM ImmunoTech to Raise Up to USD8.5 Million in Public Offering of Securities | Equity Offering | - |
AIM ImmunoTech Inc |
| 17 Jan 2023 | AIM Immunotech Enters into Agreement with AstraZeneca and Erasmus Medical Center | Partnership | - |
Erasmus MC
AIM ImmunoTech Inc AstraZeneca Plc |
| 06 Oct 2021 | AIM ImmunoTech Inc Enters Phase II Clinical Trial Agreement with Amarex Clinical Research LLC for rintatolimod (GDCT0435475) | Contract Service Agreement |
AIM ImmunoTech Inc
AIM ImmunoTech Inc AIM ImmunoTech Inc AIM ImmunoTech Inc |
Amarex Clinical Research LLC
Amarex Clinical Research LLC
Amarex Clinical Research LLC
Amarex Clinical Research LLC
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer